50% off Premium Yearly

NASDAQ:SIBN
This summary was created by AI, based on 1 opinions in the last 12 months.
SI-BONE (SIBN-Q) is currently facing significant financial challenges, as indicated by expert reviews highlighting substantial monetary losses. The lower-than-expected performance raises concerns about the company's ability to generate sustainable profits going forward. Experts suggest that the ongoing losses may hinder the company’s growth prospects and could lead to a reevaluation of its business strategy. Additionally, the instability in financial health places pressure on management to address operational inefficiencies that are contributing to these losses. Overall, while SI-BONE holds potential in a specialized market, the urgency to turn around its financial trajectory cannot be understated.
SI-BONE is a American stock, trading under the symbol SIBN (previously SIBN-Q on Stockchase) on the NASDAQ (SIBN). It is usually referred to as NASDAQ:SIBN or SIBN
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on SIBN (previously SIBN-Q on Stockchase). 0 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for SI-BONE.
SI-BONE was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for SI-BONE.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for SI-BONE.
SI-BONE is covered by Stockchase experts and is worth watching.
On 2026-06-12, SI-BONE (SIBN) stock closed at a price of $15.42.
Are losing too much money.